Patent US3954802A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3954802A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted-ureido derivatives of penam 3-carboxylic acid and cephem 4-carboxylic acid

Assignee: Novartis Corp
•
Filing: 1973-03-22
•
Granted: 1976-05-04
•
Expires: 1993-03-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 6-Acylamino-penam-3-carboxylic acids and 7-acylamino-3-cephem-4-carboxylic acids in which the acyl group has the formula ##EQU1## in which R 1 is hydrogen, R 2 is optionally substituted phenyl, thienyl or furyl, or R 1 and R 2 together are optionally substituted cycloalkyl, and B is a radical which is bonded via a sulphur atom or is bonded to oxygen or sulphur with the interposition of an optionally substituted CH 2 -group.

Inventors

  • 👤 Karoly Kocsis
  • 👤 Bruno Fechtig
  • 👤 Hans Bickel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 10:54
CPC Classifications
C; C07; C07C; C07C265/00; C07C265/16; C07D; C07D307/00; C07D307/02; C07D307/34; C07D307/38; C07D307/52; C07D307/56; C07D307/68; C07D333/00; C07D333/02; C07D333/04; C07D333/26; C07D333/38; C07D499/00

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 146 words
A compound of the formula ##EQU14## wherein R 3 denotes a free carboxyl group and, if R 1 and R 2 are separate, R 1 is hydrogen and R 2 is phenyl, thienyl or furyl, and, if R 1 and R 2 are combined, they form together with the carbon atom, cycloalkyl of 4 to 7 carbon atoms, and wherein B denotes a radical of the formula ##EQU15## wherein x represents carbonyloxy or sulphonyl, R 5 represents hydrogen, lower alkyl, phenyl, thienyl, furyl or pyridyl and R 6 represents (a) lower alkyl or lower alkyl mono substituted by halogen, lower alkoxy, phenoxy or lower alkanoloxy or (b) phenyl, naphthyl, benzyl, furyl, thienyl, furfuryl, thenyl, pyridyl, pyrazinyl or pyrimidyl or phenyl, naphthyl, benzyl, furyl, thienyl, furfuryl, thenyl, pyridyl, pyrazinyl or pyrimidyl mono substituted by lower alkyl, lower alkoxy, halogen or nitro, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 146 words
A compound of the formula ##EQU14## wherein R 3 denotes a free carboxyl group and, if R 1 and R 2 are separate, R 1 is hydrogen and R 2 is phenyl, thienyl or furyl, and, if R 1 and R 2 are combined, they form together with the carbon atom, cycloalkyl of 4 to 7 carbon atoms, and wherein B denotes a radical of the formula ##EQU15## wherein x represents carbonyloxy or sulphonyl, R 5 represents hydrogen, lower alkyl, phenyl, thienyl, furyl or pyridyl and R 6 represents (a) lower alkyl or lower alkyl mono substituted by halogen, lower alkoxy, phenoxy or lower alkanoloxy or (b) phenyl, naphthyl, benzyl, furyl, thienyl, furfuryl, thenyl, pyridyl, pyrazinyl or pyrimidyl or phenyl, naphthyl, benzyl, furyl, thienyl, furfuryl, thenyl, pyridyl, pyrazinyl or pyrimidyl mono substituted by lower alkyl, lower alkoxy, halogen or nitro, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 97 words
A compound according to claim 1 wherein R 3 denotes a free carboxyl group, R 1 represents hydrogen and R 2 represents phenyl and B represents ##EQU16## and wherein R 5 ' represents hydrogen, lower alkyl, phenyl, thienyl, furyl or pyridyl and R 6 ' represents (a) lower alkyl or lower alkyl mono substituted by halogen, lower alkoxy, phenoxy or lower alkanoloxy or (b) phenyl, naphthyl, benzyl, furyl, thienyl, furfuryl, thenyl, pyridyl, pyrazinyl or pyrimidyl or phenyl, naphthyl, benzyl, furyl, thienyl, furfuryl, thenyl, pyridyl, pyrazinyl or pyrimidyl mono substituted by lower alkyl, lower alkoxy, halogen or nitro.
Claim 4
Dependent Claim 33 words
A compound according to claim 1 wherein R 3 denotes a free carboxyl group, R 1 represents hydrogen and R 2 represents phenyl and B denotes lower alkanoyloxymethyl, α-lower alkanoyloxyethyl or α-lower alkanoyloxybenzyl.
Claim 5
Dependent Claim 29 words
A compound according to claim 1 wherein R 3 denotes a free carboxyl group, R1 represents hydrogen and R 2 represents phenyl and B denotes phenyl sulphonylmethyl or naphthylsulphonylmethyl.
Claim 6
Dependent Claim 19 words
A compound as claimed in claim 1, which is 6-[D-α-(3-α-(2-thenoyloxy)- propionyl-1-ureido)- phenyl-acetamido]-penicillanic acid or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim 27 words
A compound as claimed in claim 1, which 6-[D-α-(3-p-chlorophenylsulphonylacetyl-1-ureido)-phenylacetamido]-penicillanic acid or a pharmaceutically acceptable alkali metal, alkaline earth metal, earth metal, ammonium or amine addition salt thereof.
Claim 8
Dependent Claim 17 words
A compound as claimed in claim 1 which is 6-[D(-)-α-(3-L(+)-α-(2-furoyloxy)-propionyl-1-ureido)-phenylacetamido]-penicillanic acid or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 17 words
A compound as claimed in claim 1, which is 6-[D(-)-α-(3-D,L-α-acetoxy-(2-furylacetyl)-1-ureido-phenylacetamido]-penicillanic acid or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim 17 words
A compound as claimed in claim 1, which is 6-[D(-)-α-(3-D,L-α-acetoxy-(2-thienylacetyl)-1-ureido)-phenylacetamido]-penicillanic acid or a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim 17 words
A compound as claimed in claim 1, which is 6-[D(-)-α-(3-L(+)-α-(p-nitrobenzoyloxy)-propionyl-1-ureido)-phenylacetamido]-penicillanic acid or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim 17 words
A compound as claimed in claim 1, which is 6-[D(-)-α-(3-L(+)-α-chloroacetoxy-propionyl-1-ureido)-phenylacetamido]-penicillanic acid or a pharmaceutically acceptable salt thereof.
Claim 13
Dependent Claim 16 words
A compound as claimed in claim 1, which is 6-[D(-)-α-(3-L(+)-α-phenoxyacetoxy-propionyl-1-ureido)-phenylacetamido]-penicillanic acid or pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

GB1250611A Cited
US3481922A Cited
US3483188A Cited
US3579501A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-05-04 1979-11-03 1980-05-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-05-04 1983-11-03 1984-05-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-05-04 1987-11-03 1988-05-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag